Why is Thyrocare Tech. falling/rising?

As of 15-Jul, Thyrocare Technologies Ltd is experiencing a price increase, currently at Rs 1,168.00, reflecting a rise of 6.0 or 0.52%. The stock has shown strong performance recently, gaining 8.65% over the last two days and achieving a new 52-week high of Rs 1,179.85. Despite this positive movement, it underperformed its sector by 0.92% today. The company has demonstrated impressive returns over various periods, including a 27.97% increase year-to-date and an 82.51% rise over the past year. Positive factors contributing to this upward trend include high management efficiency with a return on equity (ROE) of 20.45%, consistent positive results over the last five quarters, and a significant growth in operating profit of 67%. However, there are concerns regarding long-term growth, as operating profit has declined at an annual rate of -0.80% over the past five years, and the stock is trading at a premium compared to its peers.
Broader market context indicates that while Thyrocare Technologies has outperformed the benchmark Sensex in the short term, with a 9.85% increase over the past week compared to a decline of 1.36% for the index, the stock's performance is not without risks. The company's high valuation, with a price-to-book ratio of 11.3, raises concerns about its sustainability, especially given that 100% of promoter shares are pledged, which could exert downward pressure in a falling market. Despite these risks, the stock's liquidity remains strong, with a significant increase in delivery volume, suggesting robust investor interest. Overall, the combination of strong recent performance and underlying risks creates a complex picture for Thyrocare Technologies Ltd.